why choose us

Clinical Trials Search

Showing 19,060 of 132,963 result(s)
Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans

Status: Completed

Condition: Esophagus Cancer

Interventions: Use of ActivSight in patients undergoing laparoscopic or robot assisted esophagectomy.

Date: 2022-10-17

Effects of Telerehabilitation-based Exercises in Cystic Fibrosis

Status: Completed

Condition: Cystic Fibrosis

Interventions: Group 1: Group exercises via Zoom application Group 2: Individual exercises via Zoom application Group 3: Routine treatment

Date: 2022-10-16

Risk Factors for Adverse Outcomes of Endovascular Revascularization in Lower Extremity Arteriosclerosis Occlusion

Status: Completed

Condition: Peripheral Arterial Occlusive Disease

Interventions: percutaneous balloon dilatation, stent implantation, plaque resection, laser plasty, cutting balloon, drug balloon, cryoballoplasty, thrombolytic ther

Date: 2022-10-16

Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients

Status: Completed

Condition: Gout

Interventions: Xanthine Oxidase Inhibitor

Date: 2022-10-16

MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER DISEASE (GD3)

Status: Completed

Condition: Gaucher Disease, Type 3

Interventions: This is an observational study looking at brain chemicals related to oxidative stress and inflammation using magnetic resonance spectroscopy (MRS).

Date: 2022-10-16

Immunogenicity Assessment of Subjects Receiving Rabies Post-exposure Prophylaxis in Cambodia

Status: Completed

Condition: Rabies Post-exposure Prophylaxis

Interventions: Biological: Intramuscular (IM) rabies post-exposure prophylaxis
one-site, 0.5 mL at Day 0, D3, D7 and D14
Biological: Intradermal (ID) rabie

Date: 2022-10-16

SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy

Status: Completed

Condition: HIV Associated Neurocognitive Disorder

Interventions: SV2A PET scan with radiotracer [11C]UCB-J for imaging synaptic density in the brain

Date: 2022-10-16

Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese

Status: COMPLETED

Condition: Obesity

Interventions: Human monoclonal antibody to the activin receptor type II

Date: 2022-10-16

Study of Zotiraciclib for Recurrent High-Grade Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

Status: Completed

Condition: Brain Tumor

Interventions: Zotiraciclib will be given orally at the DL1, DL-1, or DL 2 once a day on days 1, 4, 8, 11, 15, 18 of every 28-days cycle (18 cycles total).

Date: 2022-10-15

Decolonization to Reduce After-Surgery Events of Surgical Site Infection

Status: Completed

Condition: Surgical Site Infection

Interventions: Used for daily showering;bathing for 30 days after hospital discharge.

Date: 2022-10-15